Tilray Inc – LSE:0Z6Y.L

Tilray stock price today

GBP 847
+829.46
+4731.72%

Tilray stock price monthly change

-38.38%
month

Tilray stock price quarterly change

-2.50%
quarter

Tilray key metrics

Market Cap
 1
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Tilray stock price history

Tilray stock forecast

Tilray financial statements

Tilray other data

Tilray
Executives

Insider Compensation
Mr. Brendan Kennedy (1972) Chairman, Pres & Chief Executive Officer $592,150
Mr. Andrew Pucher (1983) Chief Corporation Devel. Officer $253,990
Ms. Kathryn P. Dickson (1965) Pres of Manitoba Harvest USA, LLC $130,230
Mr. Michael C. Kruteck Chief Financial Officer
Mr. Jon Edward Levin Chief Operating Officer
Ms. Dara Redler Gen. Counsel & Corporation Sec.
Mr. Sascha Mielcarek Managing Director of Europe
Ms. Rita Seguin Chief HR Officer
Mr. Greg Christopher Executive Vice President of Operations
Mr. Josh Eades Chief Science Officer

Frequently Asked Questions (FAQ)

  • What's the price of Tilray stock today?

    One share of Tilray stock can currently be purchased for approximately $847.

  • When is Tilray's next earnings date?

    Unfortunately, Tilray's (0Z6Y.L) next earnings date is currently unknown.

  • Does Tilray pay dividends?

    No, Tilray does not pay dividends.

  • How much money does Tilray make?

    Tilray has a market capitalization of 1.

  • What is Tilray's stock symbol?

    Tilray Inc is traded on the LSE under the ticker symbol "0Z6Y.L".

  • What is Tilray's primary industry?

    Company operates in the Pharmaceuticals sector and Pharmaceuticals, Biotechnology & Life Sciences industry.

  • How do i buy shares of Tilray?

    Shares of Tilray can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Tilray's key executives?

    Tilray's management team includes the following people:

    • Mr. Brendan Kennedy Chairman, Pres & Chief Executive Officer(age: 53, pay: $592,150)
    • Mr. Andrew Pucher Chief Corporation Devel. Officer(age: 42, pay: $253,990)
    • Ms. Kathryn P. Dickson Pres of Manitoba Harvest USA, LLC(age: 60, pay: $130,230)
    • Mr. Michael C. Kruteck Chief Financial Officer
    • Mr. Jon Edward Levin Chief Operating Officer
    • Ms. Dara Redler Gen. Counsel & Corporation Sec.
    • Mr. Sascha Mielcarek Managing Director of Europe
    • Ms. Rita Seguin Chief HR Officer
    • Mr. Greg Christopher Executive Vice President of Operations
    • Mr. Josh Eades Chief Science Officer

  • How many employees does Tilray have?

    Tilray Inc employs 1,030 workers.

  • When Tilray went public?

    Tilray Inc is publicly traded company for more then 7 years since IPO on 19 Jul 2018.

  • What is Tilray's official website?

    The official website for Tilray is tilray.com.

  • Where are Tilray's headquarters?

    Tilray is headquartered at 1100 Maughan Rd, Nanaimo, BRITISH COLUMBIA.

  • How can i contact Tilray?

    Tilray's mailing address is 1100 Maughan Rd, Nanaimo, BRITISH COLUMBIA and company can be reached via phone at +1 206 432 9325.

Tilray company profile:

Tilray Inc

tilray.com
Exchange:

LSE

Full time employees:

1,030

Industry:

Pharmaceuticals, Biotechnology & Life Sciences

Sector:

Pharmaceuticals

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, Israel, Ireland, New Zealand, South Africa, Switzerland, the United States, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.

+1 206 432 9325
1100 Maughan Rd
Nanaimo, BRITISH COLUMBIA

:
ISIN: US88688T1007
CUSIP: 88688T100